NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Insilica

Insilica

Private
Bethesda, MarylandHealthcare & Life Scienceshttps://insilica.co/

Last Round

Grant

Sep 1, 2024

Total Funding Raised

$4.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Insilica is a bioinformatics and AI toxicology company that provides a platform and software tools, including Sysrev and ToxIndex, to automate and optimize regulatory-grade chemical safety reports and systematic literature reviews.

Sector

Healthcare & Life Sciences

Verticals

Compliance & Risk, Medical AI, Vertical SaaS, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting, Freemium, Usage-Based SaaS

AI Layer

Application

Keywords

chemical risk assessmenttoxicology softwareAI literature reviewregulatory reportingsystematic review softwarehuman-in-the-loop AIHITLagentic AIevidence synthesisAI agentRegTechenvironmental health risk assessmentEHRRAauditable AIbioinformatics softwareGovTechFAIR dataSBIR grants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insilica Comparables

Compare Insilica with similar companies based on industry and business-model similarity.

Insilica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Insilica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2024
GrantSep 15, 2023
GrantSep 1, 2022
GrantMay 1, 2021
GrantSep 1, 2020
Grant
Sep 1, 2020

Key People

Founding team and executive leadership

Tom Luechtefeld

Chief Executive Officer

Executive Team

Insilica Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors increased 82% MoM.

  • Nov 17, 2024

    Monthly visitors grew 68% MoM.

Insilica Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Insilica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Insilica's valuation, stock price, and market status.

Firmographic Details

HeadquartersBethesda, Maryland
Employee Range8
Year Founded2017
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.